Description of the OFSEP sample collection on 15 December 2021

The OFSEP collection is composed of samples taken from biological cohorts patients (OFSEP kit: blood and urine mandatory, cerebrospinal fluid (CSF) and faeces optional) and from HD cohort patients (blood sample).

Biological cohorts include radiologically isolated syndromes (RIS), clinically isolated syndromes (CIS), relapsing-remitting MS patients (RRMS) untreated, primary progressive MS patients (PPMS) untreated, related neurological syndromes (NMOSD), acute disseminated encephalomyelitis (ADEM), progressive multifocal leukoencephalopathy (LEMP) and Covid-19.

Patients included in HD cohort are RRMS, secondary progressive MS (SPMS) or PPMS.

On 15 December 2021, samples have been taken from 1,994 patients of biological cohorts and 2,668 patients of HD cohort. The always available samples are stored in 29 biological resource centers.

Patients Patient number Blood* PBMC** Urine CSF Faeces
RIS 141 141 140 126 74 5
CIS (McDo-) 325 325 299 305 217 12
CIS (McDo+) 721 721 383 378 383 20
RRMS 1932 1932 219 221 138 28
SPMS 323 323 15 16 9 2
PPMS 379 379 244 226 165 13
NMOSD 480 180 474 404 39 8
ADEM 18 18 18 14 3 0
Covid-19 26 26 25 21 0 0

* serum, EDTA plasma, DNA

** PBMC: peripheral blood mononuclear cells